This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Zebrafish: a convenient tool for myelopoiesis research
Cell Regeneration Open Access 03 January 2023
-
Estrogens revert neutrophil hyperplasia by inhibiting Hif1α-cMyb pathway in zebrafish myelodysplastic syndromes models
Cell Death Discovery Open Access 16 July 2022
-
Systemic inoculation of Escherichia coli causes emergency myelopoiesis in zebrafish larval caudal hematopoietic tissue
Scientific Reports Open Access 11 November 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Scott EW, Simon MC, Anastasi J, Singh H . Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 1994; 265: 1573–1577.
Dahl R, Walsh JC, Lancki D, Laslo P, Iyer SR, Singh H et al. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor. Nat Immunol 2003; 4: 1029–1036.
Jin H, Li L, Xu J, Zhen F, Zhu L, Liu PP et al. Runx1 regulates embryonic myeloid fate choice in zebrafish through a negative feedback loop inhibiting Pu.1 expression. Blood 2012; 119: 5239–5249.
Dakic A, Wu L, Nutt SL . Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis? Trends Immunol 2007; 28: 108–114.
Steidl U, Rosenbauer F, Verhaak RG, Gu X, Ebralidze A, Otu HH et al. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells. Nat Genet 2006; 38: 1269–1277.
Zhu X, Zhang H, Qian M, Zhao X, Yang W, Wang P et al. The significance of low PU.1 expression in patients with acute promyelocytic leukemia. J Hematol Oncol 2012; 5: 22.
Mueller BU, Pabst T, Osato M, Asou N, Johansen LM, Minden MD et al. Heterozygous PU.1 mutations are associated with acute myeloid leukemia. Blood 2002; 100: 998–1007.
Rosenbauer F, Wagner K, Kutok JL, Iwasaki H, Le Beau MM, Okuno Y et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet 2004; 36: 624–630.
Metcalf D, Dakic A, Mifsud S, Di Rago L, Wu L, Nutt S . Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia. Proc Natl Acad Sci USA 2006; 103: 1486–1491.
Stoletov K, Klemke R . Catch of the day: zebrafish as a human cancer model. Oncogene 2008; 27: 4509–4520.
Orkin SH, Zon LI . Hematopoiesis: an evolving paradigm for stem cell biology. Cell 2008; 132: 631–644.
Dakic A, Metcalf D, Di Rago L, Mifsud S, Wu L, Nutt SL . PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J Exp Med 2005; 201: 1487–1502.
Pigneux A, Perreau V, Jourdan E, Vey N, Dastugue N, Huguet F et al. Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results. Haematologica 2007; 92: 1327–1334.
Rabbani A, Finn RM, Ausio J . The anthracycline antibiotics: antitumor drugs that alter chromatin structure. Bioessays 2005; 27: 50–56.
Anderson KL, Smith KA, Pio F, Torbett BE, Maki RA . Neutrophils deficient in PU.1 do not terminally differentiate or become functionally competent. Blood 1998; 92: 1576–1585.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (Grant No.: 81270631; Grant No.: 31271564); the National Basic Research Program of China (Grant No.: 2012CB945102); Guangdong Province International Science and Technology Cooperation Program (Grant No.: 2010B05100017), Guangzhou Science and Technology Support Program (Grant No.: 11A62121172), and the General Research Fund from the Research Grants Council of HKSAR (Grant No.: HKUST6/CRF/09).
Author-contributions
JPS, WL, LL, JHC and MW designed the research, performed experiments and analyzed data. YYZ, AYL, WQZ, ZLW and WJL designed the research and analyzed data.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Sun, J., Liu, W., Li, L. et al. Suppression of Pu.1 function results in expanded myelopoiesis in zebrafish. Leukemia 27, 1913–1917 (2013). https://doi.org/10.1038/leu.2013.67
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2013.67
This article is cited by
-
Zebrafish: a convenient tool for myelopoiesis research
Cell Regeneration (2023)
-
Estrogens revert neutrophil hyperplasia by inhibiting Hif1α-cMyb pathway in zebrafish myelodysplastic syndromes models
Cell Death Discovery (2022)
-
Irf8 regulates the progression of myeloproliferative neoplasm-like syndrome via Mertk signaling in zebrafish
Leukemia (2018)
-
c-myb hyperactivity leads to myeloid and lymphoid malignancies in zebrafish
Leukemia (2017)
-
Systemic inoculation of Escherichia coli causes emergency myelopoiesis in zebrafish larval caudal hematopoietic tissue
Scientific Reports (2016)